Pei-Shan HSIEH,Yi-Chun TSAI,Chung-Wei KUO,Hsieh-Hsun HO,Hung-Chih LIN,Jiu-Yao WANG
申请号：
US16039800
公开号：
US20190358273A1
申请日:
2018.07.19
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides a lactobacillus strain-containing pharmaceutical composition and food composition for improving of kidney disease and inhibiting inflammation, which comprises an isolated lactic acid bacteria strain. The isolated lactic acid bacteria strain is at least one selected from a group including BLI-02 strain, CGMCC No. 15212, Bifidobacterium longum subsp. infantis, TYCA06 strain, CGMCC No. 15210, Lactobacillus acidophilus, VDD088 strain, CGMCC No. 15211, Bifidobacterium bifidum, and combinations thereof.
